Biotech | October 11, 2025
Dr. Jitendra Singh inaugurates 10th Annual "Cell and Gene Therapy" symposium
Several technologies for hemoglobinopathies are being transferred to commercial partners
Several technologies for hemoglobinopathies are being transferred to commercial partners
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
Pfizer will participate in TrumpRx.gov, a direct-to-patient purchasing platform offering discount up to 85%
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
The entity will undertake the installation, operation, and maintenance of sewage treatment plants
Subscribe To Our Newsletter & Stay Updated
